Taysha Gene Therapies TSHA
NASDAQ TSHA
$4.74 -0.13 (-2.67%)
At close: Oct 1, 2026 · 4:00 PM EDT

Taysha Gene Therapies (TSHA) Shares Outstanding (2019 - 2026)

Updated

Taysha Gene Therapies (TSHA) recorded Shares Outstanding of 369.04 million in Q2 2026, up 23.8% from 297.99 million a year earlier and up 0.7% from the prior quarter.

Analysis

Taysha Gene Therapies (TSHA) Shares Outstanding (2019 - 2026) Analysis & Trends

For FY2025, Taysha Gene Therapies reported Shares Outstanding of 319.71 million, up 27.8% from FY2024.

  • Annual Shares Outstanding has increased for six straight years, with a five-year compound annual growth rate of 78.5% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding came in at 250.13 million in FY2024 (+115.4%), 116.12 million in FY2023 (+164.2%), 43.95 million in FY2022 (+16.7%) and 37.65 million in FY2021 (+113.1%).
  • The Q2 2026 figure is the highest quarterly Shares Outstanding in data going back to Q4 2019.
  • On a year-over-year basis, Shares Outstanding has increased for 23 consecutive quarters, with growth averaging 49.1% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding ran from 3.2% in Q1 2022 to 265.5% in Q1 2024.
  • Per Business Quant, the preceding three quarters came in at 366.63 million (Q1 2026), 319.71 million (Q4 2025) and 353.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.94 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.70 Mn
10 Taysha Gene Therapies 1.58 Bn 1.58 Bn - 369.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 369.04 Mn
Mar 31, 2026 366.63 Mn
Dec 31, 2025 319.71 Mn
Sep 30, 2025 353.31 Mn
Jun 30, 2025 297.99 Mn
Mar 31, 2025 269.31 Mn
Dec 31, 2024 250.13 Mn
Sep 30, 2024 267.82 Mn
Jun 30, 2024 232.82 Mn
Mar 31, 2024 231.25 Mn
Dec 31, 2023 116.12 Mn
Sep 30, 2023 125.70 Mn
Jun 30, 2023 64.24 Mn
Mar 31, 2023 63.26 Mn
Dec 31, 2022 43.95 Mn
Sep 30, 2022 40.94 Mn
Jun 30, 2022 40.14 Mn
Mar 31, 2022 38.17 Mn
Dec 31, 2021 37.65 Mn
Sep 30, 2021 38.00 Mn
API Access

Taysha Gene Therapies Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=TSHA&period=max&api_key=YOUR_API_KEY